## Abstract Cognitive dysfunction is one of the most incapacitating non‐motor symptoms of Parkinson's disease (PD). Some cognitive deficits are thought to be related to abnormal dopamine homeostasis. The latter is influenced by catechol‐O‐methyltransferase (COMT), an enzyme that degrades dopamine.
Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease
✍ Scribed by Lonneke M.L. de Lau; Dagmar Verbaan; Johan Marinus; Peter Heutink; Jacobus J. van Hilten
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 1006 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background:
The A‐allele of the catechol‐O‐methyltransferase (COMT) Val158Met polymorphism is associated with decreased enzymatic activity and higher dopamine availability.
Methods:
We studied 219 patients with PD who were free of dyskinesias at baseline and underwent thorough annual examinations.
Results:
The A‐allele of the COMT Val158Met polymorphism was related to an increased risk of developing dyskinesias during follow‐up, in a dose‐dependent manner (adjusted hazard ratios for the AG and AA genotypes [compared to GG]: 2.09 [95% confidence interval (CI), 1.07–4.06] and 2.81 [CI, 1.43–5.54], respectively).
Conclusions:
This finding suggests that genetic factors may affect susceptibility to dyskinesias in PD. © 2011 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract ## Objective Genetic polymorphisms of the noradrenergic pathway can be factors to predict the effect of antidepressants when their pharmacological mechanisms of action include the noradrenergic system. The purpose of the present study was to determine whether the tyrosine hydroxylase (
Substitution therapy with levodopa and a peripheral inhibitor of aromatic L-amino acid decarboxylase (AADC) is the cornerstone in the treatment of Parkinson's disease. Chronic therapy with levodopa, however, is associated with the occurrence of motor complications that are partially related to the p
## Abstract High and low catechol‐__O__‐methyltransferase (COMT) activity is significantly determined by thermostability, which is caused by a valine/methionine~108~ polymorphism associated with polymorphic G/A~1947~ bases, in exon 4 of the COMT gene. Our allelic association study on this polymorph
## Abstract We explored the potential effect of catechol‐__O__‐methyltransferase (COMT) genetic polymorphism on the pharmacokinetics and pharmacodynamics of a standard oral dose of levodopa in patients with Parkinson's disease (PD). We prospectively collected blood samples for COMT genotyping from